TY - JOUR
T1 - Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests.
AU - Merlo, Daniel
AU - Kalincik, Tomas
AU - Zhu, Chao
AU - Gresle, Melissa
AU - Lechner-Scott, Jeannette
AU - Kilpatrick, Trevor
AU - Barnett, Michael
AU - Taylor, Bruce
AU - Buzzard, Katherine
AU - Darby, David
AU - Butzkueven, Helmut
AU - van der Walt, Anneke
N1 - Funding Information:
Michael Barnett has received institutional support for research, speaking and/or participation in advisory boards for Biogen, Merck, Novartis, Roche and Sanofi Genzyme and research support from the Nerve Research Foundation, University of Sydney.
Funding Information:
Katherine Buzzard has served on advisory boards for Merck and Biogen; has received speakers honoraria and/or conference support from Biogen , Merck, Sanofi Genzyme, Teva, Novartis and Roche; has received research grants from CSL and Grifols.
Funding Information:
Anneke van der Walt has received travel support and served on advisory boards for Novartis, Biogen, Merck Serono, Roche and Teva. She receives grant support from the National Health and Medical Research Council of Australia.
Funding Information:
This work was supported by unrestricted funding from Novartis Australia (grant number CFTY720DAU08T / CFTY720D2418T) and Biogen (no grant number).
Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2022/2
Y1 - 2022/2
N2 - Background: Perceived cognitive impairment in MS is associated with adverse changes in employment capacity, sexual function, and aspects of daily living. Studies have shown relationships between perceived cognitive impairment and objective neuropsychological functioning and mood. Subjective cognitive performance in people with MS has not previously been compared to their objective performance on a computerised cognitive battery. Methods: All participants completed at least 6-monthly serial testing on the MSReactor computerised cognitive testing platform consisting of 3 reaction time tasks. These measure psychomotor processing speed (simple reaction time), attention (choice reaction time) and working memory (One back task). In addition, we collected subjective cognitive performance and patient reported outcomes of depression, anxiety and quality of life. The strength and direction of the relationships between subjective and objective performance on the cognitive tasks were examined using Kendalls rank coefficient at year 1 and year 2. We calculated partial correlation estimates where subjective performance was also associated with patient reported outcomes. Results: Subjective overall performance correlated weakly with the working memory task (Tau -0.10; (95% confidence interval (CI) -0.19, -0.01). Subjective performance also correlated weakly with depression but not anxiety or quality of life. Subjective reaction speed correlated weakly with psychomotor processing speed (Tau -0.10; CI -0.19, -0.01); and subjective accuracy correlated weakly with the attention (Tau 0.12; CI 0.03, 0.21) and working memory (Tau 0.15; CI 0.05, 0.24) tasks, respectively. Conclusion: Participants’ perceived performance on the MSReactor tests correlated only weakly with objective changes. Depression was associated with subjective cognitive performance reports. These results suggest that a person with MS’ perception of their cognitive performance is only weakly associated with cognitive changes detected using MSReactor.
AB - Background: Perceived cognitive impairment in MS is associated with adverse changes in employment capacity, sexual function, and aspects of daily living. Studies have shown relationships between perceived cognitive impairment and objective neuropsychological functioning and mood. Subjective cognitive performance in people with MS has not previously been compared to their objective performance on a computerised cognitive battery. Methods: All participants completed at least 6-monthly serial testing on the MSReactor computerised cognitive testing platform consisting of 3 reaction time tasks. These measure psychomotor processing speed (simple reaction time), attention (choice reaction time) and working memory (One back task). In addition, we collected subjective cognitive performance and patient reported outcomes of depression, anxiety and quality of life. The strength and direction of the relationships between subjective and objective performance on the cognitive tasks were examined using Kendalls rank coefficient at year 1 and year 2. We calculated partial correlation estimates where subjective performance was also associated with patient reported outcomes. Results: Subjective overall performance correlated weakly with the working memory task (Tau -0.10; (95% confidence interval (CI) -0.19, -0.01). Subjective performance also correlated weakly with depression but not anxiety or quality of life. Subjective reaction speed correlated weakly with psychomotor processing speed (Tau -0.10; CI -0.19, -0.01); and subjective accuracy correlated weakly with the attention (Tau 0.12; CI 0.03, 0.21) and working memory (Tau 0.15; CI 0.05, 0.24) tasks, respectively. Conclusion: Participants’ perceived performance on the MSReactor tests correlated only weakly with objective changes. Depression was associated with subjective cognitive performance reports. These results suggest that a person with MS’ perception of their cognitive performance is only weakly associated with cognitive changes detected using MSReactor.
KW - Attention
KW - Cognitive dysfunction
KW - Information processing
KW - Multiple sclerosis
KW - Subjective health
KW - Working memory
UR - http://www.scopus.com/inward/record.url?scp=85119522116&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2021.103393
DO - 10.1016/j.msard.2021.103393
M3 - Article
C2 - 35216774
AN - SCOPUS:85119522116
SN - 2211-0348
VL - 58
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 103393
ER -